Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT vs Vancomycin for primary C. difficile diarrhea
NCT02801656Phase 3Withdrawn
- Sponsor
- Memorial University of Newfoundland
- Start
- Dec 2020
- Primary completion
- Sep 2022
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 3 trial of Fecal Microbiota Transplantation Capsule in Clostridium difficile infection (CDI), sponsored by Memorial University of Newfoundland. Planned start Dec 2020; status: withdrawn.
02
Drugs
Fecal Microbiota Transplantation Capsule
03
Conditions
Clostridium difficile infection (CDI)
Beyond the preview
Go deeper on NCT02801656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02801656.